Is Buspirone FDA-Approved for Panic Disorder?
No, buspirone is not FDA-approved for panic disorder—it is only approved for generalized anxiety disorder (GAD). 1
FDA-Approved Indication
Buspirone hydrochloride is FDA-approved exclusively for the management of generalized anxiety disorder (GAD) or short-term relief of anxiety symptoms, not for panic disorder. 1 The FDA label specifically describes its indication for patients with persistent anxiety manifested by motor tension, autonomic hyperactivity, apprehensive expectation, and vigilance/scanning—the hallmark features of GAD. 1
Evidence for Panic Disorder
The evidence for buspirone in panic disorder is insufficient and does not support its use:
Clinical studies in panic disorder have been inconclusive, and buspirone is not recommended for routine treatment of panic disorder. 2
Research from 1990 explicitly states that buspirone's use in panic disorders requires further investigation, with studies showing inconclusive results at that time. 2, 3
A 1999 review examining buspirone's potential in various conditions beyond GAD found that relatively few placebo-controlled trials existed for panic disorder, with the evidence base remaining weak. 4
Clinical Implications
For panic disorder specifically, you should use FDA-approved first-line agents instead:
SSRIs are recommended for pediatric patients (ages 6-18) with panic disorder, though notably no specific SSRIs have FDA approval for anxiety disorders in this population. 5
SNRIs can be considered as an alternative treatment option for panic disorder in children and adolescents ages 6-18. 5
Important Caveats
The lack of FDA approval for panic disorder reflects the absence of robust efficacy data in controlled trials. 2 While buspirone has a favorable safety profile with low abuse potential and minimal sedation compared to benzodiazepines, 3 this does not translate to efficacy in panic disorder. The drug's slower onset of action (requiring gradual titration over weeks) 5 makes it particularly unsuitable for panic disorder, where rapid symptom control is often clinically necessary.
Bottom line: Choose SSRIs or SNRIs for panic disorder; reserve buspirone exclusively for GAD where it has proven efficacy and regulatory approval. 1, 2